Clinical trial Recruiting at 1 site Observational

Comparing two imaging techniques for detecting arterial obstructions in stroke patients

Official title: Accuracy of Transcranial Colour Coded Duplex Compared With CT Angiography in Diagnosing Arterial Obstructions in Acute Ischemic Strokes

Run by Sohag University · NCT06920303 · Data updated 2026-11-12

This study is testing whether a new imaging method called TCCD is better than CT angiography for finding blocked arteries in stroke patients, especially in the Egyptian population.

Quick facts

Study typeObservational
SexAll
Enrollment100 (estimated)
SponsorSohag University
Academic / other
Locations1 site (Sohag)
StatusRecruiting
StartedMay 1, 2025
Main results expectedJanuary 1, 2026
Study endsSeptember 1, 2026
Registry record updatedMay 13, 2025
Trial IDNCT06920303 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are patients presenting with acute ischemic strokes or transient ischemic attacks.

Probably not a fit

Patients with a history of cardiac arrhythmia, autoimmune diseases, or those with significant neurological disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the accuracy of transcranial colour coded duplex (TCCD) in comparison to CT angiography for detecting arterial obstructions in patients who have experienced acute ischemic strokes or transient ischemic attacks. The study focuses on understanding the prevalence of intracranial stenosis and its implications in different ethnic groups, particularly in the Egyptian population, where data is scarce. By assessing the effectiveness of TCCD, the study seeks to provide insights into a potentially less invasive imaging method for stroke diagnosis. The findings could enhance the understanding of stroke mechanisms and improve diagnostic approaches in clinical settings.

Why it matters

Potential benefit: If successful, this study could lead to improved diagnostic accuracy for ischemic strokes, potentially allowing for better-targeted treatments.

How similar studies have gone: While there is extensive data on carotid atherosclerosis in various populations, this study's focus on the Egyptian ethnic group represents a novel approach that has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* patients who have acute ischemic strokes or transient ischemic attacks .

Exclusion Criteria:

1. Patients with history of cardiac arrhythmia or discovered recently or known rheumatic heart disease.
2. Patients with history of autoimmune diseases.
3. Patients with space occupying lesion or hemorrhage in Ct brain.
4. Pregnant female.
5. Patients who refuse to participate in the study.
6. Patients who have history of allergy or developed acute kidney injury during previous dye injection.
7. Patients who have chronic kidney disease.
8. Premorbid neurological disorder (myopathy, multiple sclerosis) on neurological examination or previous investigations.
9. Inability to achieve safe vascular access.
10. Patients with insufficient temporal acoustic window.

Where it's running

  • Sohag university hospital
    Sohag, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.